Rafael Holdings and Cyclo Therapeutics extend merger deadline to March 31, 2025

Rafael Holdings, Inc.

Amendment No. 2 to Merger Agreement extends the End Date from February 15, 2025 to March 31, 2025.
Rafael Holdings holds approximately 39.5% of Cyclo Therapeutics' outstanding common stock.
Extension allows additional time for SEC to declare the Form S-4 registration statement effective.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.